Across the world, the demand for traditional medicine services is increasing. The World Health Organization has announced ＂Traditional Medicine Strategy 2002-2005＂, ＂Traditional Medicine Strategy 2014-2023＂ and ＂The Regional Strategy for Traditional Medicine in the Western Pacific 2011-2020＂ to appeal every country integrating traditional medicine into national policy and legal framework, and improving the quality, efficacy, and safety of traditional medicine. Although the 10th article on the ＂Additional Articles of the Constitution of the Republic of China＂ defined that ＂The State shall promote universal health insurance and promote the research and development of both modern and traditional medicines＂, and Taiwan also has perfect measures of Chinese medicine. Yet, most of Chinese medicine legal are detailed administration, which don’t have articles on innovative R&D, talent training, funding supply. Compared with ＂Korean Medicine and Pharmaceutics Promotion Act＂ of Korea, ＂Law of the People's Republic of China on Traditional Chinese Medicine＂ of China, legal framework of Taiwan lacks regulations of overall policies, financial subsidies, public health care, international collaboration, industrial development, etc. Furthermore, there are many obstacles on development of medical service, industry, research and talent cultivation of Chinese medicine due to insufficient administrative and financial support. The above reasons have prompted the Ministry of Health and Welfare to develop the ＂Chinese Medicine and Pharmacy Development Act＂, which has announced and implemented on December 31, 2019. ＂Chinese Medicine and Pharmacy Development Act＂ has seven chapters and twenty-four articles, which have established development policies of Chinese medicine health care, quality management and industry of Chinese medicine products, research and talent cultivation of Chinese medicine and pharmacy. And the content and description of each article is including characteristics of Chinese medicine and pharmacy, which can be used as the sources of law for the various policies of Chinese medicine and pharmacy. In addition, it is the first definition of Chinese medicine and Chinese medicine products which defining the scope of Chinese medical theory and Chinese pharmacy theory, then it will help draw up regulation or judge the rulings. Enacting regulations on awards or subsides of Chinese medicine and pharmacy, the lease of public lands for the cultivation of Chinese medicinal plants, the post-market monitoring of Chinese medicine products, and formulating development plans of Chinese medicine and pharmacy are important after legislating the Act. During the implementation process, it is necessary to improve funding support, complete communication between various departments and resource integration, focus on the key issue of Chinese medicine and pharmacy development, and refer to the results of the three times Korean medicine and pharmaceutics comprehensive plan in South Korea to improve the effectiveness of future implementations of the ＂Chinese Medicine and Pharmacy Development Act＂.